NEW YORK (GenomeWeb News) — Shares in Cepheid were up 6 percent to a new 52-week high of $12.47 in mid-afternoon trading today after the company this morning said the US Food and Drug Administration cleared one of its tests.
 
As GenomeWeb Daily News reported this morning, the company’s PCR-based Xpert MRSA test is designed to detect drug-resistant Staphylococcus aureus infections.   
  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.